SEROQUEL - 0310-0281-39 - (Quetiapine fumarate)

Alphabetical Index


Drug Information of SEROQUEL

Product NDC: 0310-0281
Proprietary Name: SEROQUEL
Non Proprietary Name: Quetiapine fumarate
Active Ingredient(s): 150    mg/1 & nbsp;   Quetiapine fumarate
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of SEROQUEL

Product NDC: 0310-0281
Labeler Name: AstraZeneca Pharmaceuticals LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022047
Marketing Category: NDA
Start Marketing Date: 20090201

Package Information of SEROQUEL

Package NDC: 0310-0281-39
Package Description: 100 TABLET, EXTENDED RELEASE in 1 DOSE PACK (0310-0281-39)

NDC Information of SEROQUEL

NDC Code 0310-0281-39
Proprietary Name SEROQUEL
Package Description 100 TABLET, EXTENDED RELEASE in 1 DOSE PACK (0310-0281-39)
Product NDC 0310-0281
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Quetiapine fumarate
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20090201
Marketing Category Name NDA
Labeler Name AstraZeneca Pharmaceuticals LP
Substance Name QUETIAPINE FUMARATE
Strength Number 150
Strength Unit mg/1
Pharmaceutical Classes Atypical Antipsychotic [EPC]

Complete Information of SEROQUEL


General Information